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a b s t r a c t
Background/objectives: The aim of this study was to assess the impact of older age (70 years) and
obesity (BMI 30) on surgical outcomes of minimally invasive pancreatic resections (MIPR). Subse-
quently, open pancreatic resections or MIPR were compared for elderly and/or obese patients.
Methods: A systematic review was conducted as part of the 2019 Miami International Evidence-Based
Guidelines on MIPR (IG-MIPR). Study quality assessment was according to The Scottish Intercollegiate
Guidelines Network (SIGN). A meta-analysis was performed to assess the impact of MIPR or open
pancreatic resections in elderly patients.
Results: After screening 682 studies, 13 observational studies with 4629 patients were included. Elderly
patients undergoing laparoscopic distal pancreatectomy (LDP) had less blood loss (117 mL, p < 0.001) and
a shorter hospital stay (3.5 days p < 0.001) than elderly patients undergoing open distal pancreatectomy
(ODP). Postoperative pancreatic fistula (POPF) B/C, major complication and reoperation rate were not
significantly different in elderly patients undergoing either laparoscopic or open pan-
creatoduodenectomy (OPD). One study compared robot PD with OPD in obese patients, indicating that
patients with robotic surgery had less blood loss (mean 250 ml vs 500 ml, p ¼ 0.001), shorter operative
time (mean 381 min vs 428 min, p ¼ 0.003), and lower rate of POPF B/C (13% vs 28%, p ¼ 0.039).
Conclusion: The current available limited evidence does not suggest that MIPR is contraindicated in
elderly or obese patients. Additionally, outcomes in MIPR are equal or more beneficial compared to the
open approach when applied in these patient groups.
© 2020 IAP and EPC. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Introduction
Between 1980 and 2013, the global prevalence of overweight
and obesity has risen by 27.5% [1]. At the same time, the proportion
of elderly patients, defined as  70 years, will continue to grow [2].
Obese patients (BMI 30) have a higher risk for comorbidities such
as diabetes mellitus, coronary artery disease and hypertension [3]
* Corresponding author. Scientific Chair of Surgery, Head of Hepatobiliary
Pancreatic and Minimally invasive Surgery, Poliambulanza Foundation Hospital, Via
Bissolati, Brescia, Italy.
E-mail addresses: n.vanderheijde@amsterdamumc.nl (N. van der Heijde),
abuhilal9@gmail.com (M. Abu Hilal).
1 Shared first authorship.
2 Shared last authorship.
Contents lists available at ScienceDirect
Pancreatology
journal homepage: www.elsevier .com/locate/pan
https://doi.org/10.1016/j.pan.2020.06.013
1424-3903/© 2020 IAP and EPC. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Pancreatology 20 (2020) 1234e1242
Downloaded for Anonymous User (n/a) at Baptist Health South Florida from ClinicalKey.com by Elsevier on October 08, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.
and might therefore be prone to worse surgical outcomes. In gen-
eral, advanced age, is correlated with higher co-morbidity and
therefore elderly patients carry a higher surgical morbidity and
mortality risk. Due to the perceived frailty, major abdominal sur-
gery such as pancreatoduodenectomymight pose bigger challenges
in old or obese patients [4,5].
Outcomes after open pancreatic resection in obese patients are
inconsistent. Some studies report longer operation duration, more
blood loss, higher postoperative pancreatic fistula (POPF) rate and
longer length of hospital stay (LOS) than in non-obese patients
[6e12]. Other studies have found no difference in perioperative
outcomes between obese and non-obese patients undergoing
pancreatic resection [13,14]. Perioperative outcomes in elderly pa-
tients after open pancreatic resections are equally inconclusive.
Older patients have a higher incidence of postoperative mortality,
cardiorespiratory morbidity, and intensive care unit admission
compared to younger patients [15,16]. In contrast, other studies,
usually derived from single-center specialty practices, found com-
parable perioperative outcomes after pancreatic resections be-
tween elderly and younger patients [10,17e19].
Several randomized controlled trials (RCT’s), systematic reviews
and meta-analyses have been performed comparing open to
minimally invasive pancreatic resections (MIPR) [20e26]. MIPR has
been shown to be associated with reduced blood loss and a shorter
LOS compared to the open approach [20,23,27,28]. However,
whether MIPR can be safely applied in older or obese patients re-
mains unclear. This systematic review aimed to assess the impact of
older age (70 years) and high BMI (30) on the surgical outcomes
of MIPR. Subsequently, a comparison between the open and mini-
mally invasive approach will be made specifically in elderly or
obese patients.
Materials and methods
This study was performed according to the Preferred Reporting
Items for Systematic reviews and Meta-Analyses (PRISMA) guide-
lines [29]. The present systematic review was performed as part of
the 2019 International Evidence-Based Guidelines for Minimally
Invasive Pancreas Resection (IG-MIPR), which collected evidence
on both laparoscopic and robotic pancreatoduodenectomy, distal
pancreatectomy, central pancreatectomy, and patient selection,
training, learning curve and minimal annual volume in order to
obtain optimal outcomes and prevent patient safety concerns [30].
Due to the nature of this study, no IRB approval or written consent
was needed.
A systematic literature search was conducted with the help of a
clinical librarian in PubMed, Cochrane and Embase databases for
studies published before January 2020. Search terms were based on
approach (e.g. minimally invasive) and procedure (e.g. pancrea-
tectomy) and patient groups (e.g. elderly). The search in Pubmed
was as follows: (“Obesity”[Mesh] OR obes*[tiab] OR older[tiab] OR
elder*[tiab]) AND (“Pancreatectomy”[Mesh] OR “Pancreatic Neo-
plasms/surgery”[Mesh] OR pancreat*[tiab]) AND (“Minimally
Invasive Surgical Procedures”[Mesh] OR “Laparoscopy”[Mesh] OR
“Robotic Surgical Procedures”[Mesh] OR laparoscop*[tiab] OR ro-
botic[tiab] OR robot-assisted[tiab] OR minimally invasive[tiab] OR
minimal invas*[tiab]).
Eligibility criteria
Studies comparing all technical approaches of minimally inva-
sive pancreatic resections (either laparoscopic, robot-assisted or
hybrid) with open pancreatic resections (OPR) or within the patient
group of interest; either high BMI or elderly age were included.
Studies in other languages than English, review articles, articles not
available in full text, duplicates and editorials were excluded.
Study selection
Titles, abstracts and full-text articles were all assessed inde-
pendently by two authors (NH and AB) to establish eligibility. All
references of included articles were manually screened for possible
additional studies. In case of conflicting assessments, consensus on
which articles to include was reached through discussion.
Assessment of methodological quality
Quality assessment of the selected studies was performed using
checklists provided by the Scottish Intercollegiate Guidelines
Network (SIGN) [31]. SIGN was established for the development of
evidence based clinical guidelines. Each study type was assessed
with a corresponding checklist, resulting in a quality level of high
(þþ), acceptable (þ), low () or unacceptable (reject).
Risk of bias was assessed using the Newcastle Ottawa scale
(NOS) by both authors independently for all studies. A maximum of
9 point could be granted, divided over 3 categories “selection of
patients,” “comparability,” and “outcome of study participants.”
Studies with a NOS score of 5 were considered as high risk for
bias.
Data extraction
In case of insufficient data, the corresponding author was con-
tacted to provide the additional information (in 1 study). The
extracted data included study design, study period, sample size and
type of surgical procedure, patient characteristics (such as sex, age,
BMI, tumor size, diagnosis), operative outcomes [conversion, blood
loss, operative time, resection margin involved (R-status)] and
postoperative outcomes (including Clavien Dindo 3 complication
[32], clinically relevant POPF Grade B/C according to the Interna-
tional Study Group on Pancreatic Fistula [33] and LOS).
Statistical analysis
Data analyses were performed using ReviewManager, (RevMan,
version 5.3, Copenhagen: The Nordic Cochrane Center, The
Cochrane Collaboration, 2014). Categorical data were presented as
frequencies and percentages. Continuous data were presented as
stated in original articles. If a minimum of 3 studies in the same
patient group had comparable reported outcome data we used
DerSimonian and Laird random effects models to pool the data [34].
The numbers of POPF B/C and sample size per group were used to
calculate odds ratios and entered means, SD and sample size per
group to calculate mean differences (MD) for LOS and blood loss.
Cochran’s Q and the I2-statistics were used to assess between-study
heterogeneity [35]. Publication bias was assessed using Egger’s test
if applicable. Statistical significance was set at p < 0.05.
Results
Search results
After removal of duplicates, a total of 682 studies were identi-
fied, which were screened on title and abstract after which 643
studies were excluded for not meeting inclusion criteria. Of the 39
studies that remained, 26 studies were excluded after full text
assessment. Of these 13 remaining studies, a total of 10 studies with
3997 patients was included in the elderly subgroup; four studies on
distal pancreatectomy and six on pancreatoduodenectomy. Overall,
three studies with 632 patients were included in the obesity
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subgroup. No additional studies were included after manually
screening the references. The PRISMA study selection flow-chart is
shown in Fig. 1 and the characteristics of all included studies are
shown in Table 1. The main perioperative outcomes per study are
summarized in Table 2 for distal pancreatectomy and Table 3 for
pancreatoduodenectomy.
Methodological quality
Using the SIGN methodology, three out of 13 studies (23%) were
of low quality with the remaining studies being of acceptable
quality. One of all 13 studies had a high risk of bias (5 NOS score)
[36]. All studies had a retrospective design and one study used
matching [37]. In the meta-analyses there was moderate to
considerable heterogeneity.
Elderly patients, distal pancreatectomy
Three studies including a total of 249 patients compared lapa-
roscopic (LDP) with open distal pancreatectomy (ODP) in elderly
patients [38e40]. Meta-analyses showed that elderly patients un-
dergoing LDP had less blood loss (MD -117; 95% CI -159 to 74;
p < 0.001) (Fig. 2a) and a shorter LOS (MD -3.6 95% CI -5.1 to -2.1;
p <0.001) (Fig. 2b) than elderly patients undergoing ODP. The rate
of POPF B/C was comparable (Fig. 2c) (OR 0.97; 95% CI 0.4 to 2.4).
There was low heterogeneity between the studies (I2 ¼ 0%). Since
only few studies were included it was difficult to test for publica-
tion bias, although Egger’s intercept suggested there was no pub-
lication bias in terms of blood loss (b ¼ 2.68, SE ¼ 1.99, p ¼ 0.20),
LOS (b ¼ 2.68, SE ¼ 2.57 and p ¼ 0.24) and POPF B/C (b ¼ 0.96,
SE ¼ 0.71 p ¼ 0.20).
In a cohort of 402 LDPs, Sahakyan et al. found that elderly pa-
tients undergoing LDP less often developed POPF (p ¼ 0.009) and
had lower readmission rates (p ¼ 0.025) compared to the younger
group. The rate of Clavien-Dindo 3 complications did not differ
significantly. The groups were comparable in terms of sex, BMI,
history of upper abdominal surgery and indication for surgery [41].
Elderly patients, pancreatoduodenectomy
Data of three studies comparing laparoscopic pan-
creatoduodenectomy (LPD) and open pancreatoduodenectomy
(OPD) in elderly patients were pooled in a meta-analysis [37,42,43].
Meta-analyses of postoperative outcomes are shown in Fig. 3. POPF
B/C rate (OR 0.57; 95% CI 0.3 to 1.3) (Fig. 3a), major complication
rate (OR 0.6; 95% CI 0.4 to 1.1)(Fig. 3b) and reoperation rate (OR 0.6;
95% CI 0.2 to 1.6) (Fig. 3c) were not statistically different between
LPD and OPD. There was low to moderate heterogeneity between
the studies (I2¼ 0e53%). Egger’s intercept suggested no publication
bias in terms of POPF B/C (b ¼ 1.85, SE ¼ 2.18, p ¼ 0.55), major
complication (b ¼ 0.05, SE ¼ 2.24, p ¼ 0.99) and reoperation rate
(b ¼ 1.22, SE ¼ 1.79, p ¼ 0.62).
Fig. 1. PRISMA flow chart of observational studies of elderly and obese patients undergoing either minimally invasive or open distal pancreatectomy.
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Of the remaining four studies, the study with the largest sample
size used the National Cancer Database (NCDB) and included pa-
tients 75 years with pancreatic adenocarcinoma undergoing
either laparoscopic n ¼ 248 (14.0%) or open pan-
creatoduodenectomy, n ¼ 1520 (86.0%). There was no difference
between the groups in terms of age, sex, receipt of neoadjuvant
chemotherapy, radiotherapy or tumor size (all p > 0.05). In peri-
operative outcomes there was no statistically significant differ-
ence in terms of readmission rates or 30-day mortality (p ¼ 0.19
and p ¼ 0.26 respectively). Ninety-day mortality was lower in the
LPD group compared to OPD (7.2% versus 12.2% respectively,
p ¼ 0.049). Data on POPF, major morbidity and reoperation were
not recorded and therefore this study could not be included in the
meta-analyses [36].
One study assessed the impact of elderly age on laparoscopic
pancreatoduodenectomy [44] and one on robotic pan-
creatoduodenectomy (RPD) [45]. The first study was a single center
study including 199 patients, 158 patients <70 years and 41
Table 1
Overview of included studies.
First author Subject Study period Sample
size
Type of MIPR Comparison (n) Study design Case matched
MIPR OPR
Elderly patients, distal pancreatectomy
Aprea et al. Elderly 2012e2015 7 15 Laparoscopic Elderly LDP (7) vs. elderly ODP (15) Retrospective No
Chen et al. Elderly 2005e2018 334 48 Laparoscopic Elderly LDP (70) vs. ODP (48) vs non- elderly LDP (264) Retrospective No
Sahakyan et al. Elderly 1997e2015 402 e Laparoscopic Elderly LDP (118) vs. non-elderly LDP (284) Retrospective No
Souche et al. Elderly 1995e2017 53 56 Laparoscopic Elderly LDP (53) vs. ODP (56) Retrospective No
Elderly patients, pancreatoduodenectomy
Buchs et al. Elderly 2007e2010 41 e Robotic Elderly (15) vs. non elderly (26) Retrospective No
Chapman et al. Elderly 2010e2013 248 1520 Laparoscopic Elderly LPD (248) vs. OPD (1520) Retrospective No
Liang et al. Elderly 2015e2018 27 19 Laparoscopic Non-elderly LPD (55) vs. Elderly LPD (27) vs. Elderly OPD (19) Retrospective No
Meng et al. Elderly 2010e2017 41 e Laparoscopic Non-elderly LPD (158) vs. Elderly LPD (41) Retrospective No
Shin et al. Elderly 2014e2017 56 270 Laparoscopic Elderly LPD (56) vs. Elderly OPD (270) Retrospective Yes
Tee et al. Elderly 2007e2014 281 579 Laparoscopic Elderly LPD (113) vs. OPD (225) vs. non-elderly LPD (168) vs. OPD (354) Retrospective No
Total Elderly 1995e2018 1490 2507
Obesity patients, distal pancreatectomy
Sahakyan et al. Obesity 1997e2015 402 e Laparoscopic Normal weight (191) vs. overweight (155) vs. obese (56) Retrospective No
Wang et al. Obesity 2004e2013 85 e Robotic Obese (28) vs. non-obese (57) Retrospective No
Obese patients, pancreatoduodenectomy
Girgis et al. Obesity 2011e2015 70 75 Robotic Obese RPD (70) vs. obese OPD (75) Retrospective No
Total Obesity 1997e2015 557 75
Abbreviations: LDP: laparoscopic distal pancreatectomy, LPD: Laparoscopic pancreatoduodenectomy, MIPR: minimally invasive pancreatic resection, OPR: open pancreatic
resection, ODP: open distal pancreatectomy, OPD: open pancreatoduodenectomy RDP: Robot distal pancreatectomy, RPD: Robot pancreatoduodenectomy.
Table 2


























Laparoscopic >70 years 186 ± 11 342 ± 104 na 11 ± 4 1 (14.3) na na 0 (0)
Open >70 years 180 ± 7 212 ± 62 e 7 ± 1 1 (6.7) na na 0 (0)
Chen et al. Laparoscopic 70 years 186 ± 54 191 ± 113 2 (2.9) 11 ± 6 7 (10.0) na 7 (10.0) na
Open 70 years 208 ± 41 292 ± 172 e 15 ± 7 5 (10.4) na 7 (14.6) na
Laparoscopic <70 years 175 ± 53 193 ± 108 4 (1.5) 10 ± 6 17 (6.4) na 21 (8.0) na
Sahakyan
et al.
Laparoscopic 70 years 162 (29e374)a 264 ± 44 0 (0) 7 ± 6 11 (9.3) 5 (4.2) 18 (15.3)b 1 (0.8)
Laparoscopic <70 years 156 (45e520)a 302 ± 62 8 (2.8) 7 ± 6 57 (20.1) 17 (6.0) 59 (20.8)b 1 (0.4)
Souche
et al.
Laparoscopic >70 years 204 ± 57 238 ± 312 na 14 ± 10 3 (6.8) 3 (6.8) 8 (18.2) 0 (0)




Laparoscopic Obese BMI 30 190 (61e480)a 200 (0e2800)a 1 (1.8) na 14 (25) na 12 (21.4)b 1 (1.8)
Laparoscopic Overweightc 158 (56e520)a 50 (0e6250)a 5 (3.2) na 27 (17.4) na 35 (22.6)b 0 (0)
Laparoscopic Normal weight 153 (29e374)a 90 (0e2000)a 1 (0.5) na 29 (15.2) na 32 (16.8)b 3 (1.6)
Wang
et al.
Robotic Obese BMI 30 252 252 1 (3.6) 8 8 (28.5) na 6 (21.4) 0
Robotic Non obese BMI
<30
253 194 3 (5.4) 10 4 (7) na 5 (8.7) 0
Abbreviations: LOS: length of stay, POPF B/C: Postoperative pancreatic fistula grade B/C, na: not available.
a ¼ Median (IQR).
b ¼ Accordion grade 3.
c BMI 25e29.9.
N. van der Heijde et al. / Pancreatology 20 (2020) 1234e1242 1237
Downloaded for Anonymous User (n/a) at Baptist Health South Florida from ClinicalKey.com by Elsevier on October 08, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.
patients 70 years. Estimated blood loss (150, (100e300 mL) vs.
150 (100e270 mL), LOS (14, 11e17 vs. 15, 12e20 days) and Clavien-
Dindo 3 complication (n ¼ 25, 15.8% vs. n ¼ 8, 19.5% p ¼ 0.57) did
not statistically significantly differ between young and older pa-
tients respectively [44]. The second study divided patients in two
groups: patients <70 years (n ¼ 26, 63.4%) and 70 years (n ¼ 15,
36.6%) respectively. Other demographic characteristics (sex, BMI,
ASA and comorbidities) were similar between the two groups.
There was no significant difference in conversion (n ¼ 2, 7.7% vs.
n ¼ 0, 0%, p ¼ 0.52) or blood loss (median 390, range 50e1500 mL
vs. 388, 80e1000 mL p ¼ 0.989) between the groups [45].
Obese patients, minimally invasive distal pancreatectomy
Two studies assessed the impact of obesity in MIDP, one with
the laparoscopic and one with the robotic approach [46,47]. The
first study divided patients in three groups: normal weight
(n ¼ 191), overweight (BMI>25; n ¼ 155), and obese (BMI>30;
n ¼ 56) patients undergoing LDP. Patients were comparable in
terms of age, sex and previous abdominal operations. Obese pa-
tients had a significantly longer operative time (p ¼ 0.009) and
increased estimated blood loss (p ¼ 0.01) compared to overweight
and normal weight patients. Equally, in using stepwise multiple
linear regression analyses, obesity independently predicted pro-
longed operative time (estimate ¼ 30.2 [95% CI, 12.1-48.3],
p ¼ 0.001) and was found to be significantly associated with an
increased intraoperative blood loss (estimate¼ 1.6 [95% CI,1.1e2.3],
p ¼ 0.01). Conversion, LOS and the number of severe complications
did not differ significantly between the three groups (p-values
respectively 0.15, 0.13 and 0.37). Multivariate logistic regression
analyses did not demonstrate an association between obesity and
postoperative morbidity (p ¼ 0.09) [46].
Wang et al. compared non-obese (n ¼ 57) with obese (n ¼ 28)
patients undergoing robotic distal pancreatectomy who were
otherwise comparable with respect to age, sex, ASA classification or
preoperative diagnosis. In peri-operative parameters there were no
significant differences in conversion rate (5.3% and 3.5% p ¼ 0.71),
mean operative time (252 versus 253 min p ¼ 0.94), mean blood
loss (193 versus 252 mL p ¼ 0.47) or mean LOS (10 versus 8 days,
p ¼ 0.14) in non-obese vs. obese patients respectively. Five (8.7%)
non-obese and six (21.4%) obese patients had a Clavien-Dindo 3
complication (p ¼ 0.495). POPF Grade B/C was seen more often in
obese patients (28.5% versus 7%) however this did not reach sta-
tistical significance (p ¼ 0.064) [47].
MIPD in obese patients
The only study found on this subject compared RPD with OPD
and divided patients in three groups: normal weight patients
(n ¼ 332), obese patients (defined as BMI  30) undergoing RPD
(n¼ 70) and obese patients undergoing OPD (n¼ 75) [48]. In obese
patients, intra-operative outcomes significantly differed between
the robotic and open cohort: operating room (OR) time was shorter
(381 min vs 428 min, p ¼ 0.003), estimated blood loss lower
(250 ml vs 500 ml, p ¼ 0.001) and number of patients requiring red
blood cell transfusions smaller (17% vs. 33%, p ¼ 0.035) in the RPD
group. The robotic cohort had a lower rate of POPF grade B/C
compared to the obese OPD cohort (13% vs 28%, p ¼ 0.039). On
multivariate analysis, obese patients (BMI 30) were more likely to
develop a Clavien-Dindo 3 complication (OR 1.59, CI 95% 1.0-2.5,
Table 3


























Robotic 70 years 420 ± 62 388 ± 282 0 (0) 14 ± 8 na 0 (0) na na
Robotic <70 years 444 ± 91 390 ± 379 2 (7.7) 11 ± 5 na 2 (7.7) na na
Chapman
et al.
Laparoscopic 75 years na na na 10 (7
e15)a
na na na 13 (7.2)
Open 75 years na na e 10 (7
e16)a
na na na 136 (12.2)
Liang
et al.
Laparoscopic 70 years 368 ± 75 200 (100e400) 2 (7.4) 12 (10
e21)
4 (15) 3 (11) 11 (41) 2 (7)
Open 70 years 369 ± 73 400 (200e700) e 18 (14
e43)
4 (21) 1 (5) 8 (42) 2 (10)
Laparoscopic <70 years 363 ± 82 100 (100e200) 5 (9) 12 (10
e16)
5 (9) 2 (4) 11 (20) 1 (2)
Meng
et al.
Laparoscopic 70 years 424 ± 109 150 (100e270) 4 (9.8) 15 (12
e20)
5 (12.2) 2 (4.9) 8 (19.5) na
Laparoscopic <70 years 432 ± 101 150 (100e300) 11 (9.7) 14 (11
e17)
17 (10.8) 10 (6.3) 25 (15.8) na
Shin et al. Laparoscopic 70 years 322 ± 56 na na 14 ± 11 4 (7.2) na 3 (5.4) na
Open 70 years 289 ± 69 na e 16 ± 13 12 (21.4) na 6 (10.7) na
Tee et al. Laparoscopic 70 years 365 ± 111 345 ± 347 5 (4.4) 8a 26 (23.0) 3 (2.7) 11 (9.7) na
Open 70 years 360 ± 90 869 ± 1118 e 9a 57 (25.3) 15 (6.7) 34 (15.1) na




Robotic Obese BMI 30 381 250 0 (0) 9 (7
e14)
9 (13.0) na 25 (36) na
Open Obese BMI  30 428 500 e 11 (8
e14)





392 300 e 9 (7
e14)
47 (14) na 92 (28) na
Abbreviations: LOS: length of stay, na: not available, POPF B/C: Postoperative pancreatic fistula grade B/C.
a ¼ Median (inter quartile range).
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p ¼ 0.036) [48].
Discussion
This systematic review and meta-analysis studied the role of
older age and obesity in minimally invasive pancreatic surgery and
compared outcomes between open and minimally invasive
pancreatic resections specifically for these two patient categories.
Regarding distal pancreatectomy, LDP appeared to be safe in elderly
patients and may have some advantages over the open procedure
in terms of intra-operative blood loss and length of hospital stay. In
obese patients, evidence suggests that outcomes between MIDP
and ODP are comparable. Regarding pancreatoduodenectomy, no
evidence was found that MIPD is inferior to OPD in elderly patients.
Only one study compared MIPD with OPD in obese patients and
found a lower rate of POPF grade B/C in the minimally invasive
group compared to open, with other peri-operative outcomes being
comparable between the two groups. All in all, current evidence is
relatively scarce and future research is highly recommended.
The first multicenter randomized controlled trial [27] and
several meta-analyses comparing MIDP with ODP demonstrated
advantages of the minimally invasive procedure in terms of blood
loss, time to functional recovery and LOS [22,23,49] The only pre-
vious systematic review that focused on elderly patients under-
going either MIDP or ODP confirmed the advantages of the
minimally invasive approach. In that study, however, the method-
ological quality of included studies was not assessed and no meta-
analysis was performed [50].
Age is a well-known risk factor for increased morbidity after
pancreatic surgery. A recent meta-analysis including 5186 patients
found that elderly patients have an increased risk of mortality
compared to younger patients after open pancreatoduodenectomy
[16]. Unfortunately, recent RCTs did not report on impact of age on
outcomes. A recent meta-analysis included 224 patients from three
RCT’s of LPD versus OPD and demonstrated no significant difference
regarding 90-day mortality, Clavien-Dindo 3 complications,
length of stay, reoperation and readmission or oncologic outcomes
between both groups. No specific analysis was done for the impact
of age or older age. Quality of evidence was rated as moderate to
very low [51].
The two included studies on obese patients undergoing distal
pancreatectomy only compared obese and non-obese patients
within the MIDP group. Wang et al. looked at 85 patients under-
going robotic distal pancreatectomy and 28.5% of the obese patients
had a POPF Grade B fistula compared to 7% of non-obese patients
[47]. Although this did not reach statistical significance, this was
most likely due to the study being underpowered. This higher
pancreatic fistula rate in obese patients is in line with previous
reports on the impact of body mass index on outcomes for distal
pancreatectomy [52]. This could be potentially explained by the
presence of a fattier and softer gland in the obese patient popula-
tion. Unfortunately, due to the design of these two studies, the
possible advantage of MIPR over the open approach cannot be
established.
Only one previous study compared a MIPR approach (RPD) with
the open approach in obese patients undergoing PD [48]. RPD was
found to be associated with less overall complications without
difference in POPF rate, DGE, reoperation or LOS, compared to OPD
[53]. When interpreting these results it should be taken into ac-
count that this study is a single center study from a very high
Fig. 2. Forest plot of studies examining the difference between laparoscopic and open distal pancreatectomy in terms of: A, perioperative blood loss. B, length of hospital stay. C,
POPF B/C.
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volume center with extensive experience in RPD.
The studies on obesity included in this systematic review all
classified obese patients as patients with a BMI of 30, however
studies suggest that patients who are prone to higher complication
rates are those with severe obesity (BMI 35). Although BMI is
commonly used to divide patient groups in different weight cate-
gories, it is debatable if this is the best way to assess adipose
composition. Some previous studies have stated that visceral or
abdominal fat are superior methods to define obesity [54,55].
No studies were identified comparing laparoscopic (non-ro-
botic) and open approaches in obese patients. By comparison, in
colorectal surgery the laparoscopic approach seems superior for
obese patients in terms of length of stay and is comparable in
perioperative and oncological outcomes [56e58].
This systematic review has some limitations. First, only few
studies specifically addressed the impact of obesity and older age
on outcomes of MIPR. Second, all types of MIPR were included,
which subsequently led to varying outcomes making it difficult to
draw conclusions for each specific approach. Third, when looking at
elderly patients definitions regarding age varied. Some studies
defined older patients as 75 years old. Heterogeneity in defini-
tions complicated comparison of the outcomes of these studies.
Besides, no studies have specifically looked at octogenarians.
Fourth, none of the now four available RCTs report specifically on
elderly or obese patients and all studies included in our review
were retrospective which could induce statistical heterogeneity
precluding firm conclusions. Fifth, heterogeneity of clinical factors
could not be addressed in current meta-analyses. Meta-regression
using clinical confounders was barred due to the limited amount of
studies included in the meta-analysis (i.e., <10 studies) and
therefore, crude pooled effect sizes were presented. The main
strength of this study is that it is the first systematic review and
meta-analysis focusing on perioperative outcomes in elderly and
obese patients undergoing MIPR.
Conclusion
This systematic review and meta-analysis indicates that there is
no evidence to suggest that elderly age and obesity are contrain-
dications for MIPR. In older patients undergoing LDP, there may be
some additional advantages over the open approach in terms of
blood loss and length of hospital stay. However, all included studies
were retrospective of nature and the number of studies to be
included were few, so no definitive recommendations can be given
and more high-quality prospective studies are needed to draw
firmer conclusions. The development and validation of a comor-
bidity index specific to pancreatic surgery that can be used in any
approach, would be beneficial for future comparisons of study
outcomes and risk assessment in clinical practice.
Fig. 3. Forest plot of studies examining the difference between laparoscopic and open distal pancreatecomy in terms of: A, POPF B/C, B, major morbidity, C, reoperation rate.
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